Skip to main content
FATE logo

FATE

Fate Therapeutics, Inc.

$0.93

8.42%

Trade Ideas Performance

Latest Closed Trade Idea

$0.93

8.42%
Loading...
We are loading your data. Please wait a moment.

Sentiment

News

4

Social

28

About

Events of Fate Therapeutics, Inc. (FATE)

Over the past six months, Fate Therapeutics' stock price increased by 45.90%, reaching $2.18 per share on October 28, 2026, up 72.62% from November 3, 2025. Recent events include reporting Q3 2026 financial results on November 5, 2026, with a net loss of $30.7 million ($0.25 per share) and revenue of $1.35 million, exceeding analyst estimates, and projecting funding to last until mid-2028. Wedbush reiterated an Outperform rating and $7.00 target on October 27, 2026. The company presented updated preliminary data for FT819 in active lupus nephritis on October 26, 2026, and appointed Jamie Harrell as SVP of Market Development and Commercial Operations on October 12, 2026. Fate Therapeutics received a $15.0 million CIRM grant for FT819's clinical development on September 25, 2026, and announced four abstracts selected for ACR Convergence 2026 on September 16, 2026. In August 2026, Piper Sandler raised its target to $8.00, and Wells Fargo lifted its target to $3.50. The Phase 2 RECLAIM-LN clinical trial for FT819 in systemic lupus nephritis was initiated on August 14, 2026. In June 2026, the collaboration with ONO Pharmaceutical Co., Ltd was expanded to include CAR NK cell candidates. In April 2026, the company received FDA RMAT designation for FT819 for active moderate to severe systemic lupus erythematosus, including lupus nephritis.

FAQ

Related Assets

Price action provided by Massive. Fundamentals, news and corporate events provided by FactSet. NLP support provided by Perplexity & Gemini. All data is provided for informational purposes only.

Make every trade make sense.

Sign up free. No card required. Three trade ideas a day, the AI analyst, the community - on us.

Get started for FREE (opens in new tab)
Edge Hound mobile app preview on iPhone

Join us and trade with people
who think like you.

The Edge Hound Discord is where serious self-directed investors talk strategy, share setups, and learn from each other. Free to join with any plan - including Free.

Free to join with any plan - including Free.

Join our Discord community (opens in new tab)